Skip to content
Markets
Deals

Cancer Drugmaker Mirati Draws Fresh Takeover Interest

  • Large pharmaceutical companies study merits of potential deal
  • Possible buyers are awaiting data expected next month
Mirati Therapeutics Inc. headquarters in California 

Mirati Therapeutics Inc. headquarters in California 

Source: Mirati Therapeutics Inc.

Updated on

Cancer drugmaker Mirati Therapeutics Inc. is attracting fresh takeover interest from large pharmaceutical companies ahead of updates on its drug pipeline, people with knowledge of the matter said. The stock rose as much as 16% on the news. 

The San Diego-based company has been weighing strategic options including a potential sale for some time, said the people, who asked to not be identified because the matter isn’t public.